A new market report forecasts that the global market for medical aesthetic devices—including laser systems, body‑contouring tools, injectables, and other cosmetic‑procedure devices—will grow from about US$ 20.1 billion in 2023 to US$ 37.9 billion by 2029.
The anticipated growth rate is a compound annual growth rate (CAGR) of 11.3 % between 2024 and 2029. Key factors fueling this expansion include the increasing popularity of minimally invasive and non‑invasive aesthetic procedures, technological advances in cosmetic‑device design (such as improved laser and energy‑based systems), a growing preference for body contouring and appearance enhancement, rising demand for breast augmentation surgeries, growth in medical tourism, and higher global prevalence of obesity.
The market segmentation that drives this growth covers device type (energy‑based devices, non‑energy‑based devices), application (facial aesthetics, skin resurfacing, body/contour procedures, etc.), end‑user type (hospitals, clinics, med‑spas), and geographic region.
Despite strong growth projections, the report notes potential headwinds: high procedural costs, inconsistent reimbursement policies, regulatory scrutiny, and potential side‑effects from cosmetic treatments may limit adoption in certain regions or populations.
